TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI; “Accentia”; “Company”), has released the results of its operations for the fiscal year ended September 30, 2006, as reflected in the Company's annual report filed with the SEC on December 29, 2006. Accentia has two operating segments consisting of specialty pharmaceuticals (Accentia Pharmaceuticals) and product development and market services (Analytica International). The Company also has an approximately 78% interest in Biovest International, Inc. ("Biovest") (OTCBB:BVTI), which is consolidated for reporting purposes with Accentia's product development and market services business. As previously announced, Accentia’s percentage ownership of Biovest is expected to decline as Biovest continues to pursue its self-funding activities.
